Ignite Creation Date:
2025-12-24 @ 10:07 PM
Ignite Modification Date:
2025-12-28 @ 10:28 AM
Study NCT ID:
NCT01134835
Status:
TERMINATED
Last Update Posted:
2015-12-03
First Post:
2010-05-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PPAR-gamma: a Novel Therapeutic Target for Asthma?
Sponsor:
University of Nottingham
Organization:
Study Overview
Official Title:
PPAR-gamma: a Novel Therapeutic Target in Asthma?
Status:
TERMINATED
Status Verified Date:
2015-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
safety concerns with pioglitazone
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To test the hypothesis that stimulation of PPAR-γ receptors has a therapeutic role in the treatment of asthma.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: